Novo Nordisk released study results showing that Wegovy was effective in helping children ages 6 to 11 with obesity lose weight and reduce their BMI|C4U|CC BY-SA 2.0
Two studies show that weight-loss medications are effective in treating obesity among children and teenagers. However, slower growth among younger users has raised questions about the drugs’ long-term effects.
Novo Nordisk released study results showing that Wegovy was effective in helping children ages 6 to 11 with obesity lose weight and reduce their BMI.
Eli Lilly's separate study also showed that Zepbound was effective in helping teens shed weight, though doctors remain split over prescribing such drugs to children with obesity.